AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Phosphagenics Half Year Financial Results-POH.AX, page-2

  1. 5,867 Posts.
    lightbulb Created with Sketch. 17381
    The arbitration against Mylan continues to progress and it is worth noting Mylan has not submitted any counterclaims. The hearing is scheduled for fourth quarter 2017.

    Possible settlement?

    Multiple new TPM®/Oxymorphone patch candidates are on track towards stability testing in third quarter 2016.


    Given that there’s only one month remaining in this quarter, it looks like tesa Labtec have been successful in coming up with multiple viable patch candidates.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
64 103305097 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 22478912 7
View Market Depth
Last trade - 16.12pm 05/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.